Clinical trial

Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease

NCT03419806

Study summary

ClinicalTrials.gov

Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Infudopa i.v. Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Infudopa s.c. Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention LCIG (Duodopa) Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-02-16

PhasePHASE1

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Interventions

Infudopa i.v.DRUG

Infudopa s.c.DRUG

LCIG (Duodopa)DRUG

Sponsors & collaborators

Vastra Gotaland Regionlead sponsor

The Swedish Research Councilcollaborator

Dizlin Medical Design ABcollaborator

Göteborg Universitycollaborator

Mapped research locations

GothenburgSweden1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03419806 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.